Durham pharma nets $238M for smallpox drug with more payouts lined up

The Durham drugmaker could get an additional $124 million in milestone payments from the sale of its smallpox treatment.

Source: bizjournals.com Health Care:Physician Practices headlines - September 28, 2022 Category: American Health Authors: Zac Ezzone Source Type: news